Back

Cardiotoxic effects of the novel anti-ErbB2 agent Ado trastuzumab emtansine

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Basic science - Translational biomarkers and cardio-renal syndrome Cancer/Cardiotoxicity HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Nicola Maurea

National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)

5 More presentations in this session

Presentation thumbnail
Ranolazine partially blunts ado trastuzumab emtansine related cardiotoxicity
Doctor N. Maurea (Naples, IT)
Abstract Slides
Presentation thumbnail
Customized laboratory TLR4 and TLR2 detection method from peripheral human blood for early detection of doxorubicin induced cardiotoxicity
Assistant Professor M. Trofenciuc (Arad, RO)
Abstract
Presentation thumbnail
Cardiorotective effect of non-peptidic pkr1 agonist against anthracycline-cardiotoxicity.
Doctor A. Gasser (Strasbourg, FR)
Abstract
Presentation thumbnail
Growth differentiation factor 15 as a predictor of acute kidney injury formation
Associate Professor I. Vyshnevska (Kharkiv, UA)
Abstract Slides
Presentation thumbnail
Neladenoson, a partial adenosine A1-receptor agonist, improves mitochondrial function in skeletal muscle of dogs with chronic heart failure
Professor H. Sabbah (Detroit, US)
Abstract Slides

Access the full session

Session thumbnail
Poster session 3 - Basic science - Translational biomarkers and cardio-renal syndrome

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources